XML 71 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1
COMMON STOCK Common Stock (Tables)
12 Months Ended
Dec. 31, 2017
Equity [Abstract]  
Schedule of Stock by Class [Table Text Block]
The following table provides a summary of our public offerings of common stock in 2016 and 2015:

Date
 
Shares Issued
 
Price per Share
 
Net Proceeds
 
 
 
 
 
 
(in millions)
September 2016
 
9,085,000

 
$
61.51

 
$
558.5

March 2016
 
5,922,500

 
50.11

 
296.6

March 2015
 
4,002,000

 
50.73

 
202.9

Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]
The following table provides a summary of the impact of our outstanding stock-based compensation plans on the results of operations for the periods presented:
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
 
 
(in thousands)
 
 
 
 
 
 
 
Stock-based compensation expense
 
$
19,353

 
$
19,502

 
$
20,068

Income tax benefit
 
(7,372
)
 
(7,296
)
 
(7,636
)
Net stock-based compensation expense
 
$
11,981

 
$
12,206

 
$
12,432

 
 
 
 
 
 
 


Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
he Compensation Committee has awarded SARs to our executive officers in 2017, 2016, and 2015. The fair value of each SAR award was estimated on the date of grant using a Black-Scholes pricing model using the following assumptions:
    
 
Year Ended December 31,
 
2017
 
2016
 
2015
 
 
 
 
 
 
Expected term of award (in years)
6.0 years

 
6.0 years

 
5.2 years

Risk-free interest rate
2.0
%
 
1.8
%
 
1.4
%
Expected volatility
53.3
%
 
54.5
%
 
58.0
%
Weighted-average grant date fair value per share
$
38.58

 
$
26.96

 
$
22.23

Schedule of Share-based Compensation, Stock Appreciation Rights Award Activity [Table Text Block]
The following table presents the changes in our SARs for all periods presented (in thousands, except per share data):
 
Year Ended December 31,
 
2017
 
2016
 
2015
 
Number of
SARs
 
Weighted-Average
Exercise
Price
 
Average Remaining Contractual
Term
(in years)
 
Aggregate Intrinsic
Value
 
Number of
SARs
 
Weighted-Average
Exercise
Price
 
Aggregate Intrinsic
Value
 
Number of
SARs
 
Weighted-Average
Exercise
Price
 
Aggregate Intrinsic
Value
Outstanding at January 1,
244,078

 
$
41.36

 
6.9

 
$
7,620

 
326,453

 
$
38.99

 
$
4,697

 
279,011

 
$
38.77

 
$
1,472

Awarded
54,142

 
74.57

 

 

 
58,709

 
51.63

 

 
68,274

 
39.63

 

Exercised

 

 

 

 
(141,084
)
 
40.16

 
2,770

 
(20,832
)
 
38.05

 
473

Outstanding at December 31
298,220

 
47.39

 
6.5

 
2,490

 
244,078

 
41.36

 
7,620

 
326,453

 
38.99

 
4,697

Exercisable at December 31
223,865

 
43.28

 
5.9

 
2,267

 
174,919

 
38.72

 
5,924

 
222,489

 
37.70

 
3,489

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]
The following table presents the changes in non-vested time-based RSUs during 2017:

 
Shares
 
Weighted-Average
Grant Date
Fair Value per Share
 
 
 
 
Non-vested at December 31, 2016
479,642

 
$
56.09

Granted
273,941

 
65.14

Vested
(266,809
)
 
57.67

Forfeited
(14,642
)
 
62.92

Non-vested at December 31, 2017
472,132

 
60.23

 
 
 
 

The following table presents the weighted-average grant date fair value per share and related information as of/for the periods presented:
 
As of/Year Ended December 31,
 
2017
 
2016
 
2015
 
(in thousands, except per share data)
 
 
 
 
 
 
Total intrinsic value of time-based awards vested
$
16,303

 
$
18,973

 
$
17,077

Total intrinsic value of time-based awards non-vested
24,334

 
34,812

 
28,029

Market price per common share as of December 31,
51.54

 
72.58

 
53.38

Weighted-average grant date fair value per share
65.14

 
58.52

 
48.88

Restricted Stock Awards, Market-Based, Valuation assumptions [Table Text Block]
he weighted-average grant date fair value per PSU granted was computed using the Monte Carlo pricing model using the following assumptions:
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
 
 
 
 
 
 
 
Expected term of award (in years)
 
3 years

 
3 years

 
3 years

Risk-free interest rate
 
1.4
%
 
1.2
%
 
0.9
%
Expected volatility
 
51.4
%
 
52.3
%
 
53.0
%
Weighted-average grant date fair value per share
 
$
94.02

 
$
72.54

 
$
66.16



Schedule of Nonvested Performance-based Units Activity [Table Text Block]
The following table presents the change in non-vested market-based awards during 2017:
 
 
Shares
 
Weighted-Average
Grant Date
Fair Value per Share
 
 
 
 
 
Non-vested at December 31, 2016
 
48,420

 
$
64.97

Granted
 
28,069

 
94.02

Vested
 
(24,140
)
 
57.35

Non-vested at December 31, 2017
 
52,349

 
84.06

 
 
 
 
 

The following table presents the weighted-average grant date fair value per share and related information as of/for the periods presented:
 
As of/Year Ended December 31,
 
2017
 
2016
 
2015
 
(in thousands, except per share data)
 
 
 
 
 
 
Total intrinsic value of market-based awards vested
$
2,687

 
$
6,562

 
$
4,293

Total intrinsic value of market-based awards non-vested
2,698

 
3,514

 
3,819

Market price per common share as of December 31,
51.54

 
72.58

 
53.38

Weighted-average grant date fair value per share
94.02

 
72.54

 
66.16